Bridgeway Capital Management, LLC Lipocine Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.24 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.3 - $0.58 $1,909 - $3,691
-6,364 Reduced 1.5%
419,300 $134,000
Q2 2022

Aug 15, 2022
BUY
$0.73 - $1.34 $181,624 - $333,392
248,800 Added 140.67%
425,664 $341,000
Q1 2022

May 16, 2022
BUY
$0.89 - $1.85 $157,408 - $327,198
176,864 New
176,864 $242,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $299M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email